Citric acid

OCA Wins "Energy Product of the Year" at 2022 Mindful Awards

Retrieved on: 
Wednesday, June 8, 2022

LOS ANGELES, June 8, 2022 /PRNewswire-PRWeb/ -- The 2022 Mindful Awards, an independent recognition platform highlighting conscious companies and products that mindfully make waves in the ever-expanding world of consumer-packaged goods, today announced organic plant-based energy drink OCA as the winner of "Energy Product of the Year" in the Beverage category. OCA is the first product to launch under WeBelivMagnus umbrella, the result of a collaboration between Beliv (a leader in the global beverage industry with a portfolio of over 40 brands in 35 countries), led by Carlos Sluman, and Magnus Media, (the media venture founded by Grammy-Award-winning artist and Latin music icon Marc Anthony).

Key Points: 
  • OCA offers consumers a tasty solution to increase energy while also treating the body the way it deserves.
  • "Thank you to the 2022 Mindful Awards for selecting OCA as the Energy Product of the Year," said Gabriela Rameriz, Head of OCA.
  • We are proud to honor OCA as this year's 'Energy Product of the Year' at the 2022 Mindful Awards," said Travis Grant, Managing Director, Mindful Awards.
  • The Mindful Awards organization is devoted to honoring mindful companies in the consumer-packaged goods industry that are setting the foundation for our future.

US Food and Drug Administration Extends Phexxi® Shelf Life to Four Years

Retrieved on: 
Thursday, June 2, 2022

SAN DIEGO, June 2, 2022 /PRNewswire/ -- Evofem Biosciences, Inc. (Nasdaq: EVFM) (Evofem) today announced that the U.S. Food and Drug Administration (FDA) has formally extended the shelf life of Phexxi (lactic acid, citric acid, potassium bitartrate)from three to four years.

Key Points: 
  • SAN DIEGO, June 2, 2022 /PRNewswire/ -- Evofem Biosciences, Inc. (Nasdaq: EVFM) (Evofem) today announced that the U.S. Food and Drug Administration (FDA) has formally extended the shelf life of Phexxi (lactic acid, citric acid, potassium bitartrate)from three to four years.
  • In May of 2020, the FDA approved Phexxi for the prevention of pregnancy.
  • The initial approval included a 30-month shelf life for Phexxi, which was extended to 36 months in April 2022 by the FDA.
  • Earlier this week, the FDA formally approved Evofem's 'Prior Approval' supplement for the shelf-life extension to 48 months.

Bio Plasticizers Market to Garner $2.1 Billion, Globally, By 2030 at 5.31% CAGR, Says Allied Market Research

Retrieved on: 
Thursday, May 26, 2022

PORTLAND, Ore., May 26, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Bio Plasticizers Market by Type (Epoxides, Sebacates, Succinic Acid, Citrates, Glycerol Esters, Others), by Application (Flooring and Walls, Film and Sheet Coverings, Wires and Cables, Coated Fabrics, Consumer Goods, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030." According to the report, the global bio plasticizers industry was estimated at $1.3 billion in 2020, and is anticipated to hit $2.1 billion by 2030, registering a CAGR of 5.31% from 2021 to 2030.

Key Points: 
  • On the other hand, high cost of bio plasticizers is expected to hamper the growth to some extent.
  • The outbreak of the pandemic has had a mixed impact on the global bio plasticizers market.
  • By type, the epoxides segment accounted for the major share in 2020, holding nearly three-fifths of the global bio plasticizers market.
  • By region, the market across Asia-Pacific had the lion's share in 2020, generating more than half of the global bio plasticizers market.

Bio Plasticizers Market to Garner $2.1 Billion, Globally, By 2030 at 5.31% CAGR, Says Allied Market Research

Retrieved on: 
Thursday, May 26, 2022

PORTLAND, Ore., May 26, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Bio Plasticizers Market by Type (Epoxides, Sebacates, Succinic Acid, Citrates, Glycerol Esters, Others), by Application (Flooring and Walls, Film and Sheet Coverings, Wires and Cables, Coated Fabrics, Consumer Goods, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030." According to the report, the global bio plasticizers industry was estimated at $1.3 billion in 2020, and is anticipated to hit $2.1 billion by 2030, registering a CAGR of 5.31% from 2021 to 2030.

Key Points: 
  • On the other hand, high cost of bio plasticizers is expected to hamper the growth to some extent.
  • The outbreak of the pandemic has had a mixed impact on the global bio plasticizers market.
  • By type, the epoxides segment accounted for the major share in 2020, holding nearly three-fifths of the global bio plasticizers market.
  • By region, the market across Asia-Pacific had the lion's share in 2020, generating more than half of the global bio plasticizers market.

Gelesis to Participate in Upcoming Investor Conferences

Retrieved on: 
Wednesday, May 18, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220518006013/en/
    Wednesday, May 25, 2022: UBS Global Healthcare Conference: Gelesis will host a presentation beginning at 8:30 a.m. Eastern Time.
  • The presentation will be webcast live here and on the Companys investor relations website at ir.gelesis.com .
  • Wednesday, June 1, 2022: Third Annual Loop Capital Conference: Gelesis will participate virtually.
  • Gelesis Holdings Inc. (NYSE: GLS) (Gelesis) is a consumer-centered biotherapeutics company and the maker of Plenity, which is inspired by nature and FDA cleared to aid in weight management.

Worldwide Potassium Citrate Industry to 2027 - Featuring Cargill, FBC Industries and Foodchem International Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, May 16, 2022

Potassium citrate (K3C6H5O7) or tri-potassium citrate, refers to a white, odorless, citric, hygroscopic crystalline powder that is manufactured by combining potassium bicarbonate and citric acid.

Key Points: 
  • Potassium citrate (K3C6H5O7) or tri-potassium citrate, refers to a white, odorless, citric, hygroscopic crystalline powder that is manufactured by combining potassium bicarbonate and citric acid.
  • It acts as an essential mineral for maintaining body fluid volume, regulating cell function, and balancing electrolytes.
  • How has the global potassium citrate market performed so far and how will it perform in the coming years?
  • What is the structure of the global potassium citrate market and who are the key players?

Feed Preservatives Market worth $6.7 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, May 13, 2022

CHICAGO, May 13, 2022 /PRNewswire/ -- According to MarketsandMarketsanalysis, the "Feed Preservatives Market by Type (Feed Acidifiers, Mold Inhibitors, Feed Antioxidants, Anticaking Agents), Livestock (Poultry, Cattle, Swine, Aquaculture), Feed Type (Compound Feed, Feed Premix, Feed Meal, Silage), and Region Global Forecast to 2027", size of feed preservatives is estimated to be valued at USD 4.8 billion in 2022.

Key Points: 
  • CHICAGO, May 13, 2022 /PRNewswire/ -- According to MarketsandMarketsanalysis, the "Feed Preservatives Market by Type (Feed Acidifiers, Mold Inhibitors, Feed Antioxidants, Anticaking Agents), Livestock (Poultry, Cattle, Swine, Aquaculture), Feed Type (Compound Feed, Feed Premix, Feed Meal, Silage), and Region Global Forecast to 2027", size of feed preservatives is estimated to be valued at USD 4.8 billion in 2022.
  • It is projected to reach USD 6.7 billion by 2027, with a CAGR of 6.7%, in terms of value between 2022 and 2027.
  • Based on Livestock, the swine segment is projected to account for the second-largest market share in the feed preservatives market.
  • By feed type, the feed preservatives market is segmented into compound feed, feed premix, feed meal, silage, and other feed types.

Feed Preservatives Market worth $6.7 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, May 13, 2022

CHICAGO, May 13, 2022 /PRNewswire/ -- According to MarketsandMarketsanalysis, the "Feed Preservatives Market by Type (Feed Acidifiers, Mold Inhibitors, Feed Antioxidants, Anticaking Agents), Livestock (Poultry, Cattle, Swine, Aquaculture), Feed Type (Compound Feed, Feed Premix, Feed Meal, Silage), and Region Global Forecast to 2027", size of feed preservatives is estimated to be valued at USD 4.8 billion in 2022.

Key Points: 
  • CHICAGO, May 13, 2022 /PRNewswire/ -- According to MarketsandMarketsanalysis, the "Feed Preservatives Market by Type (Feed Acidifiers, Mold Inhibitors, Feed Antioxidants, Anticaking Agents), Livestock (Poultry, Cattle, Swine, Aquaculture), Feed Type (Compound Feed, Feed Premix, Feed Meal, Silage), and Region Global Forecast to 2027", size of feed preservatives is estimated to be valued at USD 4.8 billion in 2022.
  • It is projected to reach USD 6.7 billion by 2027, with a CAGR of 6.7%, in terms of value between 2022 and 2027.
  • Based on Livestock, the swine segment is projected to account for the second-largest market share in the feed preservatives market.
  • By feed type, the feed preservatives market is segmented into compound feed, feed premix, feed meal, silage, and other feed types.

Evofem Biosciences to Decrease Cost of Goods 45 Percent Through New Partnership with Bora Pharmaceutical Services for the Commercial Manufacturing of Phexxi®

Retrieved on: 
Tuesday, May 10, 2022

"We conducted a comprehensive evaluation of CMOs worldwide for the best manufacturing fit for Evofem and Phexxi.

Key Points: 
  • "We conducted a comprehensive evaluation of CMOs worldwide for the best manufacturing fit for Evofem and Phexxi.
  • Evofem has initiated technical transfer activities, and Bora is expected to begin manufacturing Phexxi in the fourth quarter of 2022.
  • Initially, Bora will manufacture Phexxi for nations currently considering formal regulatory approval of Phexxi for the prevention of pregnancy, including Mexico and Nigeria.
  • Bora owns and operates multiple cGMP manufacturing facilities in Asia and North America offering services for clinical and commercial manufacturing, packaging, and analytical testing.

The 2022 Society for Biomaterials, Technology Innovation and Development Award goes to Dr. Guillermo Ameer and the Acuitive Technologies Team

Retrieved on: 
Monday, May 9, 2022

ALLENDALE, N.J., May 9, 2022 /PRNewswire/ -- It all started with a vision by Northwestern's Dr. Guillermo A. Ameer, Daniel Hale Williams Professor of Biomedical Engineering at the McCormick School of Engineering and Surgery at the Feinberg School of Medicine, who has been awarded the  2022 Technology Innovation and Development Award by the Society for Biomaterials. 

Key Points: 
  • Acuitive Technologies has received 3 FDA Product Clearances for orthopedic devices (Citrelockfixation device, Citrefixsuture anchor and CitrelockACL).
  • The Citrelockfixation device was commercially launched in September 2021 with additional products to be commercialized in Q3 2022.
  • Acuitive also has several innovative Citregenbased products being readied for the market: Citreporesynthetic graft, Citresetsettable biologic adhesive and Citrebridgerotator cuff scaffold.
  • Ameer has co-authored numerous publications in high-impact journals, book chapters, patents, and conference proceedings and has received several awards for his research."